Sionna Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -154 | -152 | -100 | -147 |
EBITDA | -26,625 | -16,760 | -19,758 | -17,921 |
EBIT | -26,779 | -17,263 | -20,278 | -18,068 |
Net Income | -26,779 | -20,440 | -20,278 | -18,068 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -21,840 | -16,830 | -15,317 | -18,153 |
Cash | 63,324 | 58,451 | 50,831 | 40,985 |
Basic Shares | 44,921 | 39,962 | 44,463 | 44,132 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -647 | -668 | ||
EBITDA | -74,621 | -61,020 | -46,680 | -40,118 |
EBIT | -75,268 | -61,688 | -47,263 | -40,240 |
Net Income | -75,268 | -61,688 | -47,263 | -40,240 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -66,674 | -52,814 | -44,815 | -37,942 |
Cash | 58,451 | 37,788 | 38,521 | 54,837 |
Basic Shares | 39,962 | 44,124 | 44,124 | 44,124 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.60 |
2025-12-31 | -$0.46 |
2025-09-30 | -$0.46 |
2025-06-30 | -$0.41 |